Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the …

…, EW Radü, L Bauer, S Dahms, V Lanius, C Pohl… - The Lancet, 2007 - thelancet.com
Background Several controlled studies provide evidence that treatment with interferon beta
in patients with a first event suggestive of multiple sclerosis (MS) delays conversion to …

Vitamin D as an early predictor of multiple sclerosis activity and progression

…, EW Radü, R Sandbrink, L Kappos, C Pohl - JAMA …, 2014 - jamanetwork.com
Importance It remains unclear whether vitamin D insufficiency, which is common in
individuals with multiple sclerosis (MS), has an adverse effect on MS outcomes. Objectives To …

250 μg or 500 μg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study

…, V Knappertz, C Kraus, R Sandbrink, C Pohl… - The Lancet …, 2009 - thelancet.com
Background The aim of the Betaferon Efficacy Yielding Outcomes of a New Dose (BEYOND)
trial was to compare the efficacy, safety, and tolerability of 250 μg or 500 μg interferon beta-…

Silent and apparent cerebral embolism after retrograde catheterisation of the aortic valve in valvular stenosis: a prospective, randomised study

…, R Fimmers, S Flacke, G Layer, C Pohl… - The Lancet, 2003 - thelancet.com
Background In most patients, severity of valvular aortic stenosis can be accurately assessed
non-invasively by echocardiography. However, retrograde catheterisation of the aortic valve …

Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 …

…, L Bauer, V Lanius, R Sandbrink, C Pohl - The Lancet …, 2009 - thelancet.com
Background The Betaferon/Betaseron in newly emerging multiple sclerosis for initial treatment
(BENEFIT) trial investigated the effect of treatment with interferon beta-1b after a clinically …

Tumor-specific T cell activation by recombinant immunoreceptors: CD3ζ signaling and CD28 costimulation are simultaneously required for efficient IL-2 secretion and …

…, T Marquardt, C Heuser, L Usai, C Pohl… - The Journal of …, 2001 - journals.aai.org
Recombinant immunoreceptors with specificity for the carcinoembryonic Ag (CEA) can
redirect grafted T cells to a MHC/Ag-independent antitumor response. To analyze receptor-…

Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score

…, M Tyblova, P Lelkova, E Havrdova, C Pohl… - The Lancet …, 2009 - thelancet.com
Background Prediction of susceptibility to multiple sclerosis (MS) might have important
clinical applications, either as part of a diagnostic algorithm or as a means to identify high-risk …

[HTML][HTML] Lack of association between antimyelin antibodies and progression to multiple sclerosis

J Kuhle, C Pohl, M Mehling, G Edan… - … England Journal of …, 2007 - Mass Medical Soc
Background Patients with a single episode of neurologic dysfunction and brain magnetic
resonance imaging (MRI) scans suggestive of multiple sclerosis are at high risk for clinically …

Determination of carbohydrates by anion exchange chromatography with pulsed amperometric detection

RD Rocklin, CA Pohl - Journal of Liquid Chromatography, 1983 - Taylor & Francis
Carbohydrates such as sugar alcohols, monosaccharides, disaccharides, and other
oligosaccharides are separated as anions by ion exchange chromatography with a sodium …

Chronic inflammatory bowel disease and cancer.

C Pohl, A Hombach, W Kruis - Hepato-gastroenterology, 2000 - europepmc.org
Colorectal cancer represents the major cause for excess morbidity and mortality by malignant
disease in ulcerative colitis as well as in Crohn's disease. The risk for ulcerative colitis …